مصطفى قاسم
Kassem, Moustapha.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Kassem, M.
قاسم، مصطفى
VIAF ID: 7008162 (Personal)
Permalink: http://viaf.org/viaf/7008162
Preferred Forms
-
100 1 _
‡a
Kassem, M.
-
100 1 _ ‡a Kassem, Moustapha (sparse)
-
100 1 _
‡a
Kassem, Moustapha
-
100 1 _
‡a
Kassem, Moustapha
-
100 1 _ ‡a Kassem, Moustapha
-
100 1 0
‡a
Kassem, Moustapha
-
100 1 _ ‡a Kassem, Moustapha
-
100 1 _ ‡a Kassem, Moustapha
-
100 1 _ ‡a Kassem, Moustapha.
-
100 1 _ ‡a قاسم، مصطفى
-
100 0 _
‡a
مصطفى قاسم
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Adipocytes médullaires et ostéoporose liée au vieillissement. |
|
| Cellular and molecular effects of growth hormones and estrogen on human bone cells, 1997: |
|
| Comparison of regenerative tissue quality following matrix-associated cell implantation using amplified chondrocytes compared to synovium-derived stem cells in a rabbit model for cartilage lesions |
|
| Effect of PTH treatment on bone healing in insufficiency fractures of the pelvis: a systematic review |
|
| Identification of a clinical signature predictive of differentiation fate of human bone marrow stromal cells |
|
| Mechanosensitivity of dental pulp stem cells is related to their osteogenic maturity. |
|
| Medullary adipocytes and age-related osteoporosis |
|
| Mesenchymal stem cells: cell biology and potential use in therapy. |
|
| Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation |
|
| Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics. |
|
| microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. |
|
| microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. |
|
| miR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation |
|
| Myeloma-modified adipocytes exhibit metabolic dysfunction and a senescence-associated secretory phenotype (SASP) |
|
| Neonatal High Bone Mass With First Mutation of the NF-κB Complex: Heterozygous De Novo Missense |
|
| New factors controlling the balance between osteoblastogenesis and adipogenesis. |
|
| Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations |
|
| Paolo Bianco |
|
| Parameters in Three-Dimensional Osteospheroids of Telomerized Human Mesenchymal (Stromal) Stem Cells Grown on Osteoconductive Scaffolds That Predict In Vivo Bone-Forming Potential |
|
| Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin |
|
| PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages. |
|
| Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal |
|
| Pleiotropic effects of cancer cells' secreted factors on human stromal (mesenchymal) stem cells |
|
| Prevention and treatment of age-related diseases |
|
| Primary mesenchymal stem cells in human transplanted lungs are CD90/CD105 perivascularly located tissue-resident cells |
|
| Proteomic Validation of Transcript Isoforms, Including Those Assembled from RNA-Seq Data |
|
| Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E |
|
| The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens |
|
| Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation |
|
| Sarcomas as a mise en abyme of mesenchymal stem cells: exploiting interrelationships for cell mediated anticancer therapy. |
|
| Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro |
|
| Self-assembled composite matrix in a hierarchical 3-D scaffold for bone tissue engineering. |
|
| Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. |
|
| Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia |
|
| Separate developmental programs for HLA-A and -B cell surface expression during differentiation from embryonic stem cells to lymphocytes, adipocytes and osteoblasts |
|
| Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study. |
|
| Simple additive manufacturing of an osteoconductive ceramic using suspension melt extrusion. |
|
| Single-cell high-content imaging parameters predict functional phenotype of cultured human bone marrow stromal stem cells |
|
| siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells. |
|
| Skeletal stem cells in space and time. |
|
| Skeletal (stromal) stem cells: an update on intracellular signaling pathways controlling osteoblast differentiation |
|
| Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. |
|
| Stable isotope labelling with amino acids in cell culture for human embryonic stem cell proteomic analysis |
|
| Stem cells: potential therapy for age-related diseases. |
|
| Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo |
|
| Surface-modified functionalized polycaprolactone scaffolds for bone repair: in vitro and in vivo experiments |
|
| System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation |
|
| TAFA2 Induces Skeletal (Stromal) Stem Cell Migration Through Activation of Rac1-p38 Signaling |
|
| Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathway |
|
| Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment |
|
| Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. |
|
| Telomere dysfunction reduces microglial numbers without fully inducing an aging phenotype |
|
| Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients |
|
| Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells. |
|
| Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. |
|
| TGFβ1-Induced Differentiation of Human Bone Marrow-Derived MSCs Is Mediated by Changes to the Actin Cytoskeleton. |
|
| TiO |
|
| TiO(2)-based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment |
|
| Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene |
|
| Tools to covisualize and coanalyze proteomic data with genomes and transcriptomes: validation of genes and alternative mRNA splicing |
|
| Transcription factor ZNF25 is associated with osteoblast differentiation of human skeletal stem cells |
|
| Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors |
|
| Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice |
|
| Tumour microenvironment and radiation response in sarcomas originating from tumourigenic human mesenchymal stem cells. |
|
| Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. |
|
| Ultrastructure of human osteoblasts and associated matrix in culture |
|
| The use of hTERT-immortalized cells in tissue engineering |
|
| The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. |
|
| The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background |
|
